Subject matters | Details | Categories |
---|---|---|
Economic Development, Employment and Training, Federal-Provincial Relations, Health, Regional Development, Science and Technology, Taxation and Finance
|
Strategic Investment Fund
Industrial Research Assistance Program
National Research Council funding for advanced therapy manufacturing
|
Grant, Contribution or Other Financial Benefit, Policies or Program, Legislative Proposal, Bill or Resolution
|
End date of the last completed financial year: 2024-03-31
Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
---|---|---|
Innovation, Science and Economic Development Canada (ISED) | $913,068.00 | Yes |
Address:
661 University Ave.
Suite 1002 , ON Canada
Toronto, ON M5G 1M1
Canada
Telephone number:
416-978-3751
Fax number:
416-978-1368
Michael May, President and CEO
Centre for the Commercialization of Regenerative Medicine / Centre de commercialisation de la médecine régénérative is not a subsidiary of any other parent companies.
Centre for the Commercialization of Regenerative Medicine / Centre de commercialisation de la médecine régénérative is not a coalition.
The activities of Centre for the Commercialization of Regenerative Medicine / Centre de commercialisation de la médecine régénérative are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
WILLIAM MANTEL | No public offices held